
United States · Cosmetics startup
Repairogen is developing premium anti-aging skincare ingredients and products based on a platform technology invented at an ivy-league medical research institution.
Funding reportedLast round: Seed
Repairogen is developing premium anti-aging skincare ingredients and products based on a platform technology invented at an ivy-league medical research institution.
Products incorporating its proprietary and scientifically proven technology will provide customers with healthier and younger looking skin. Repairogen's core scientific innovation significantly enhances the natural DNA-repair process in skin cells. The link between DNA damage and premature skin aging is well established, and leads to many of the undesirable traits associated with aged skin, including wrinkles, dark spots, dryness, and a lack of elasticity. Research conducted by the inventor of Repairogen's technology revealed that a cell's natural mechanism for DNA-repair is greatly enhanced by interfering with the activity of a single protein. By blocking the activity of this specific protein, Repairogen's proprietary technology directly targets the root cause of skin aging: DNA damage.
Funding, as reported
From the SEC filings it signed: 2 on the team.
What they build
Known for
diplomatic relationsconsumersonline gamblingjackpot strategiesonline casinoorganization innovationgamblingslot onlinecross-border resource sharinginformation technology & servicesorganization reform strategiesslot cheat toolscosmeticsstrategyinternational diplomacyresource management in organizations
Built with from their website
IoTViewport MetaGoogle PlayAIMobile FriendlyNode.jsRemoteNginxAndroidCircle
Ubuntu
Add your raise, your deck and your story, and put Repairogen Corporation in front of investors. Or tell us what we have wrong.